Roger V.
- Country
- Germany
- Department
- n/a
Research Overview
- Phase 3 Randomized Open‑Label Study of Switching to Lenacapavir Combined with Teropavimab and Zinlirvimab in Virologically Suppressed Adults with HIV‑1
- Evaluation of a Weekly Oral Islatravir/Lenacapavir Regimen Versus Standard Antiretroviral Therapy in Virologically Suppressed HIV-1 Patients
- Evaluation of the Efficacy and Safety of GS-1720 and GS-4182 Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Patients
Data & Insights
Has run more than one trial at 20 of 60 partner sites.
Specializations
HIV Treatment Innovation
This investigator specializes in advancing treatment options for HIV-1 infection, with particular focus on developing simplified treatment regimens for virologically suppressed patients.
- Weekly Oral Therapy Development
- Viral Suppression Management
- Alternative Treatment Regimens
The investigator explores novel therapeutic approaches including islatravir/lenacapavir combinations and innovative formulations like GS-1720/GS-4182 against established treatments.
Treatment Optimization
The researcher focuses on evaluating the effectiveness of transitioning patients from standard care to simplified weekly dosing regimens in virologically suppressed HIV patients.
- Treatment Switching Strategies
- Long-term Efficacy Assessment
- Comparative Treatment Studies
Their work encompasses the evaluation of fixed-dose combination tablets against conventional daily therapeutic approaches.
Clinical Innovation
The investigator specializes in developing alternative treatment paradigms for HIV management, focusing on patient-centric approaches to antiretroviral therapy.
- Novel Drug Combinations
- Treatment Simplification
- Maintenance Therapy
Their research evaluates innovative therapeutic strategies aimed at maintaining viral suppression while reducing treatment burden.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.